Thinking of joining a study?

Register your interest

NCT05864586 | COMPLETED | Nicotine


Developing E-liquid Product Standards (Sweet Spot Study)
Sponsor:

Ohio State University Comprehensive Cancer Center

Information provided by (Responsible Party):

Theodore wagers

Brief Summary:

The Sweet Spot Study aims to evaluate the effect of e-liquids with nicotine varying in freebase (FB) levels and concentrations on the appeal of electronic cigarettes (ECs) in young adult EC users with minimal/no history of smoking and older adult smokers.

Condition or disease

Nicotine

Nicotine Vaping

E-cigarette Use

Intervention/treatment

Vaping study EC A

Vaping study EC B

Vaping study EC C

Vaping study EC D

Vaping study EC E

Vaping study EC F

Vaping study EC G

Vaping study EC H

Vaping study EC I

Vaping study EC J

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 150 participants
Masking : DOUBLE
Primary Purpose : PREVENTION
Official Title : Nicotine Concentration and Forms: Differential Appeal to Smokers Versus Non-Smokers
Actual Study Start Date : 2023-05-30
Estimated Primary Completion Date : 2024-02-26
Estimated Study Completion Date : 2024-02-26

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 21 Years to 50 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion criteria
  • 1. Young adult e-cigarette user or older adult smoker
  • 2. Willing to abstain from all nicotine product use for 12 hours prior to the study visit
  • 3. Read and speak English
  • Exclusion criteria
    • 1. Currently attempting to quit nicotine products
    • 2. Currently pregnant, planning to become pregnant, or breastfeeding
    • 3. Current or past use of tobacco products other than e-cigarettes or cigarettes
    • 4. Self-reported diagnosis of lung disease
    • 5. Self-reported new or unstable cardiovascular disease

Developing E-liquid Product Standards (Sweet Spot Study)

Location Details

NCT05864586


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Ohio

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States, 43210

Loading...